Emerging Trends to Drive Osteoporosis Treatment Market Growth at 5.1% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Osteoporosis Treatment Market Size Growth Forecast: What to Expect by 2025?
The market size for osteoporosis treatment has experienced consistent expansion in the past few years. It is projected to magnify from $13.96 billion in 2024 to $14.62 billion in 2025, progressing at a compound annual growth rate (CAGR) of 4.8%. This advancement during the historical duration can be credited to factors such as the rise in aging population, implementation of hormone replacement therapies, supplementation of calcium and vitamin D, the augmentation of diagnostic instruments, and the incorporation of digital health solutions.

How Will the Osteoporosis Treatment Market Size Evolve and Grow by 2029?
In the coming years, the osteoporosis treatment market is projected to witness significant growth, reaching $17.84 billion in 2029 with a compound annual growth rate (CAGR) of 5.1%. This anticipated growth during this period is linked with increasing sedentary lifestyles, escalating instances of secondary osteoporosis, emergence of virtual bone fracture clinics, gene therapy for osteoporosis, and a heightened focus on bone health in men. Notable trends projected for this period include the development of biologics, the incorporation of artificial intelligence, the use of blockchain for bone health records, and the implementation of machine learning.

View the full report here:
https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report

What Drivers Are Propelling the Growth of Osteoporosis Treatment Market Forward?
The osteoporosis treatment market is expected to thrive due to the escalating prevalence and incidence of osteoporosis. Osteoporosis is a skeletal disease characterized by alterations in bone strength and composition or a decrease in bone mass and mineral density. Osteoporosis medication primarily works by decelerating the pace of bone degeneration. Concurrently, hormone-based methods such as estrogen are beneficial in preserving bone density, particularly if started shortly after menopause. For example, Amgen, a biopharmaceutical corporation based in the US, forecasted in May 2022 that annual fractures attributable to osteoporosis are anticipated to surge by 68% to 3.2 million by 2040. Additionally, the National Library of Medicine, a national health professional resource in the US, reported that around 549,000 new fragility fractures occur each year in the UK, with a third of these instances involving men. This figure is predicted to go up by 19.6% by 2030 due to an aging population. Consequently, the escalating prevalence and incidence of osteoporosis are fostering growth in the osteoporosis treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12166&type=smp

Which Emerging Trends Are Transforming the Osteoporosis Treatment Market in 2025?
Large corporations active in the osteoporosis treatment market are concentrating on the creation of advanced injectable treatments for osteoporosis in order to maintain their market standing. Injectable treatments for osteoporosis are medications administered through injection to avoid bone deterioration and minimize the chance of fracture in those with osteoporosis. These alternatives offer a precise approach to augment bone density and boost skeletal health. For example, Apotex Corp., a pharmaceutical company based in Canada, introduced the Teriparatide Injection in November 2023. This is a pre-filled pen designed for single-patient use to treat osteoporosis. The pen delivers 28 daily doses of 20 mcg each from a concentration of 250 mcg/mL. This product aims to increase accessibility to economical treatment for nearly 10 million Americans affected by osteoporosis. The genesis of this product reflects Apotex's commitment to the production of complex generic drugs, thereby making sure patients get top-quality treatments.

What Are the Key Segments in the Osteoporosis Treatment Market?
The osteoporosis treatment market covered in this report is segmented -

1) By Drug Type: Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog, Rank Ligand (RANKL) Inhibitor
2) By Route Of Administration: Oral, Injectable, Other Routes
3) By Distribution Channel: Hospitals, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:
1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid
2) By Calcitonin: Salmon Calcitonin, Synthetic Calcitonin Formulations
3) By Hormone Therapy: Estrogen Replacement Therapy, Combination Hormone Therapy (Estrogen And Progesterone)
4) By Selective Estrogen Receptor Modulators (SERMs), Raloxifene, Bazedoxifene
5) By Parathyroid Hormone-Related Protein (PTHrP) Analog: PTH Analog (Teriparatide), Other PTHrP Analogues
6) By Rank Ligand (RANKL) Inhibito: Denosumab

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12166&type=smp

Who Are the Key Players Shaping the Osteoporosis Treatment Market's Competitive Landscape?
Major companies operating in the osteoporosis treatment market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck and Co Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline Pharmaceutical Ltd., Takeda Pharmaceutical Company, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Corporation, AstraZeneca Plc., Viatris Inc., Teva Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Ltd, Dr. Reddy's Laboratories, Gedeon Richter Plc., Celltrion Inc., Luye Pharma Group, Ligand Pharmaceuticals Incorporated, Radius Health Inc., Haoma Medica Ltd., EffRx Pharmaceuticals SA

What Geographic Markets Are Powering Growth in the Osteoporosis Treatment Market?
North America was the largest region in the osteoporosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12166

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.